AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $20,012,896 | +2907.2% | 464,121 | +1858.3% | 0.13% | +2050.0% |
| Q4 2022 | $665,496 | +79.4% | 23,700 | +109.7% | 0.01% | +100.0% |
| Q4 2021 | $371,000 | -69.4% | 11,300 | -48.7% | 0.00% | -76.9% |
| Q2 2021 | $1,214,000 | -15.2% | 22,035 | -20.6% | 0.01% | -23.5% |
| Q1 2021 | $1,432,000 | +82.4% | 27,736 | +23.7% | 0.02% | +13.3% |
| Q3 2020 | $785,000 | +15.8% | 22,428 | +77.0% | 0.02% | +66.7% |
| Q2 2020 | $678,000 | +196.1% | 12,668 | +95.9% | 0.01% | -35.7% |
| Q1 2020 | $229,000 | -60.6% | 6,468 | -41.2% | 0.01% | -85.9% |
| Q3 2016 | $581,000 | +82.7% | 11,000 | +40.3% | 0.10% | -23.8% |
| Q1 2016 | $318,000 | – | 7,841 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |